20.03.2023 - - RVLP records exceptional year-over-year growth with UPNEEQ launch into the medical aesthetics market - - Full year 2022 total revenues of $49.7 million, an increase of $32.2 million, or 184%, over 2021 - - Full year 2022 UPNEEQ net product sales .
09.01.2023 - - Expects fourth quarter 2022 preliminary UPNEEQ net product sales of approximately $12.1 million, representing an increase of 21% over the third quarter 2022, and approximately $36.5 million for full year 2022 - - Approximately 4,300 cumulative . Seite 1
/PRNewswire/ Revision Skincare®, a leading medical-grade professional skincare brand, announced today a partnership with RVL Pharmaceuticals, Inc. the owner.
30.08.2022 - DALLAS and BRIDGEWATER, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) - Revision Skincare, a leading medical-grade professional skincare brand, announced today a partnership with RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL”), the owner of UPNEEQ, the . Seite 1